Briefly, increasing neuronal SMN levels (4-fold by E15) using a prion (PrP)-SMN cDNA transgene corrects the SMA phenotype seen in severe SMA mice [101], suggesting that elevated neuronal SMN expression is required during the perinatal developmental period. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.